by The Roskamp Institute | Feb 17, 2020 | News
Disappointingly, and somewhat surprisingly, two drugs aimed at halting alzheimer’s disease by reducing levels of the amyloid protein in the brain have failed in a late-stage clinical trial. The clinical trial sponsored by Washington University, called DIAN-TU,...
by The Roskamp Institute | Nov 18, 2019 | News
We are once again extremely happy to report that our recent Open House event has smashed all previous records for attendance. It is only with your support and participation that we are able to push the boundaries of science for treatment of diseases like...
by The Roskamp Institute | Sep 24, 2019 | News
The Roskamp Institute will be hosting its annual Open House honoring veterans and military personnel on November 11th, 2019. This event is open to the public and will run from 10 a.m. to 1 p.m., showcasing Institute research and clinical programs of particular...
by The Roskamp Institute | Jun 28, 2019 | News
The Roskamp Institute scientists have a long history of research examining the causes and potential cures for neurological disorders, particularly dementias such as Alzheimer’s Disease. During several decades of research it has become abundantly clear that one of the...
by The Roskamp Institute | Jun 24, 2019 | News
The Roskamp Institute is pleased to announce that two more students have earned their doctorates through the Institute’s unique program, bringing the total number of graduates to 11 since the program’s inception. Moustafa Algamal became the tenth student to earn his...
by The Roskamp Institute | Mar 21, 2019 | News
Very unfortunately, today Biogen announced that it’s late-stage clinical trials for Alzheimer’s Disease using the drug Aducanumab have failed. Aducanumab was designed to target one of the main pathologies in Alzheimer’s Disease, namely, amyloid accumulation....
